QuidelOrtho Corp (QDEL) director gains 1,252 shares from RSU release
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
QuidelOrtho Corp director Michael Edward L. reported compensation-related equity activity. He received 1,252 shares of common stock through the release and conversion of restricted stock units on June 6, 2026, at a stated price of $0.00 per share as part of his director compensation. Following these awards and conversions, he holds approximately 29,433 common shares directly. Footnotes explain the restricted stock units were previously reported, each unit represents one common share, and their release was deferred under QuidelOrtho’s deferred compensation program for participating non-employee directors.
Positive
- None.
Negative
- None.
Insider Trade Summary
1,252 shares exercised/converted
Mixed
4 txns
Insider
Michael Edward L.
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units (Converted) | 963 | $0.00 | -- |
| Exercise | Restricted Stock Units (Premium) | 289 | $0.00 | -- |
| Grant/Award | Common Stock | 963 | $0.00 | -- |
| Grant/Award | Common Stock | 289 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Units (Converted) — 0 shares (Direct, null);
Restricted Stock Units (Premium) — 0 shares (Direct, null);
Common Stock — 29,144 shares (Direct, null)
Footnotes (1)
- Reflects release of restricted stock units that were previously reported on a Form 4. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule.
Key Figures
Common shares from RSU release: 1,252 shares
Award tranche 1: 289 shares
Award tranche 2: 963 shares
+3 more
6 metrics
Common shares from RSU release
1,252 shares
Restricted stock units converted to common stock on June 6, 2026
Award tranche 1
289 shares
Common stock acquired from RSU release on June 6, 2026
Award tranche 2
963 shares
Common stock acquired from RSU release on June 6, 2026
Post-transaction holdings
29,433 shares
Common stock directly held after June 6, 2026 transactions
Exercise price per share
$0.00 per share
Stated price for common stock received from RSU conversions
Derivative exercises
1,252 shares
Total restricted stock units exercised/converted
Key Terms
restricted stock units, derivative security, deferred compensation program, non-employee directors
4 terms
restricted stock units financial
"Reflects release of restricted stock units that were previously reported on a Form 4."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
deferred compensation program financial
"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors"
non-employee directors financial
"deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule"
Non-employee directors are board members who do not work for the company as salaried employees and usually do not hold day-to-day management roles. They act like outside referees or independent coaches, providing oversight, asking tough questions, and protecting shareholders’ interests; investors care because these directors help ensure management is accountable, reduce conflicts of interest, and influence decisions that affect company strategy and long-term value.
FAQ
What insider transactions did QuidelOrtho Corp (QDEL) report for Michael Edward L.?
QuidelOrtho Corp reported that director Michael Edward L. acquired 1,252 shares of common stock on June 6, 2026. These shares came from the release and conversion of previously granted restricted stock units as part of his non-employee director compensation.
Were the QuidelOrtho (QDEL) insider transactions open-market purchases or sales?
The reported QuidelOrtho transactions were not open-market trades. They reflect the release and conversion of restricted stock units into common shares at a stated price of $0.00 per share, consistent with stock-based compensation for a non-employee director.
What do the restricted stock unit footnotes mean in the QuidelOrtho (QDEL) Form 4?
The footnotes explain that each restricted stock unit equals one common share of QuidelOrtho and that the units were previously reported. Their release was deferred under QuidelOrtho’s deferred compensation program for participating non-employee directors, following the director’s elected schedule.
Does the QuidelOrtho (QDEL) Form 4 show any stock option exercises or remaining derivatives?
The Form 4 shows the exercise/conversion of restricted stock units into common shares, coded as derivative transactions. The derivative summary is empty afterward, indicating no remaining restricted stock units related to these specific awards are shown in this filing excerpt.